Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $854 - $1,829
24 New
24 $1,000
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $1,496 - $2,146
-26 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $1,885 - $2,617
26 New
26 $2,000
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $12,814 - $17,615
-142 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $1,311 - $1,949
14 Added 10.94%
142 $18,000
Q1 2021

May 12, 2021

BUY
$116.57 - $155.01 $4,313 - $5,735
37 Added 40.66%
128 $17,000
Q4 2020

Feb 16, 2021

BUY
$99.61 - $142.12 $9,064 - $12,932
91 New
91 $12,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Standard Family Office LLC Portfolio

Follow Standard Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Standard Family Office LLC with notifications on news.